Wenwen Ding
Nantong, 226001, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 32 publications
Microbial SCFAs as epigenetic mediators: fine-tuning the gut-brain axis in neurodegenerative disorders.
Journal: Current research in microbial sciences
Published: March 09, 2026
Integrated multi-omics profiling identifies a convergent gut-metabolic-immune signature in Alzheimer's disease.
Journal: Free radical biology & medicine
Published: February 25, 2026
Impact of carbapenem-resistant Klebsiella pneumoniae infection on gut microbiota and host immunity: a case-control study.
Journal: Microbiology spectrum
Published: November 20, 2025
Choline serves as the primary active compound of anti-aging tablets and targets PTGS2 to alleviate neuronal damage in Alzheimer's disease by modulating ferroptosis and apoptosis in nerve cells.
Journal: Behavioural brain research
Published: July 10, 2025
The microbiota-gut-brain axis in depression: unraveling the relationships and therapeutic opportunities.
Journal: Frontiers in immunology
Published: June 10, 2025
Gut microbiota dysbiosis and systemic immune dysfunction in critical ill patients with multidrug-resistant bacterial colonization and infection.
Journal: Journal of translational medicine
Published: June 02, 2025
Schizophrenia-associated alterations in fecal mycobiota and systemic immune dysfunction: a cohort study of elderly Chinese patients.
Journal: Frontiers in immunology
Published: April 08, 2025
Gut microbiota-driven neuroinflammation in Alzheimer's disease: from mechanisms to therapeutic opportunities.
Journal: Frontiers in immunology
Published: February 24, 2025
Harnessing the human gut microbiota: an emerging frontier in combatting multidrug-resistant bacteria.
Journal: Frontiers in immunology
Published: January 20, 2025
Last Updated: 09/26/2026